Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors

Tekijä Fecher, Leslie A, Sharfman, William H
Julkaisussa Biologics (2015)

Ipilimumab and Its Toxicities: A Multidisciplinary Approach

Tekijä Fecher, Leslie A., Agarwala, Sanjiv S., Hodi, F. Stephen, Weber, Jeffrey S.
Julkaistu 2013

Metastatic melanoma with diffuse melanosis histologically after stable response to talimogene laherparepvec therapy

Tekijä Rizzo, Jason M., Fecher, Leslie A., Chan, May P., Durham, Alison B.
Julkaisussa JAAD Case Rep (2018)

Metastatic Merkel cell carcinoma response to nivolumab

Tekijä Walocko, Frances M., Scheier, Benjamin Y., Harms, Paul W., Fecher, Leslie A., Lao, Christopher D.
Julkaisussa J Immunother Cancer (2016)

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab

Tekijä Walocko, Frances M., Scheier, Benjamin Y., Harms, Paul W., Fecher, Leslie A., Lao, Christopher D.
Julkaisussa J Immunother Cancer (2017)

An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome

Tekijä Young, Kelly Z., Fossum, Sara L., Lowe, Lori, Else, Tobias, Fecher, Leslie A., Demirci, Hakan, Cha, Kelly B.
Julkaisussa JAAD Case Rep (2020)

Acute visual loss after ipilimumab treatment for metastatic melanoma

Tekijä Wilson, Melissa A., Guld, Kelly, Galetta, Steven, Walsh, Ryan D., Kharlip, Julia, Tamhankar, Madhura, McGettigan, Suzanne, Schuchter, Lynn M., Fecher, Leslie A.
Julkaisussa J Immunother Cancer (2016)

Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study

Tekijä Chu, Emily Y., Wanat, Karolyn A., Miller, Christopher J., Amaravadi, Ravi K., Fecher, Leslie A., Brose, Marcia S., McGettigan, Suzanne, Giles, Lydia R., Schuchter, Lynn M., Seykora, John T., Rosenbach, Misha
Julkaisussa J Am Acad Dermatol (2012)

Collapse of the CD27+ B cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers

Tekijä Carpenter, Erica L., Mick, Rosemarie, Rech, Andrew J., Beatty, Gregory L., Colligon, Theresa A., Rosenfeld, Myrna R., Kaplan, David E., Chang, Kyong-Mi, Domchek, Susan M., Kanetsky, Peter A., Fecher, Leslie A., Flaherty, Keith T., Schuchter, Lynn M., Vonderheide, Robert H.
Julkaistu 2009

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

Tekijä Lin, Heng, Wei, Shuang, Hurt, Elaine M., Green, Michael D., Zhao, Lili, Vatan, Linda, Szeliga, Wojciech, Herbst, Ronald, Harms, Paul W., Fecher, Leslie A., Vats, Pankaj, Chinnaiyan, Arul M., Lao, Christopher D., Lawrence, Theodore S., Wicha, Max, Hamanishi, Junzo, Mandai, Masaki, Kryczek, Ilona, Zou, Weiping
Julkaisussa J Clin Invest (2018)

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression

Tekijä Lin, Heng, Wei, Shuang, Hurt, Elaine M., Green, Michael D., Zhao, Lili, Vatan, Linda, Szeliga, Wojciech, Herbst, Ronald, Harms, Paul W., Fecher, Leslie A., Vats, Pankaj, Chinnaiyan, Arul M., Lao, Christopher D., Lawrence, Theodore S., Wicha, Max, Hamanishi, Junzo, Mandai, Masaki, Kryczek, Ilona, Zou, Weiping
Julkaisussa J Clin Invest (2018)

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Tekijä Kim, Kevin B., Kefford, Richard, Pavlick, Anna C., Infante, Jeffrey R., Ribas, Antoni, Sosman, Jeffrey A., Fecher, Leslie A., Millward, Michael, McArthur, Grant A., Hwu, Patrick, Gonzalez, Rene, Ott, Patrick A., Long, Georgina V., Gardner, Olivia S., Ouellet, Daniele, Xu, Yanmei, DeMarini, Douglas J., Le, Ngocdiep T., Patel, Kiran, Lewis, Karl D.
Julkaisussa J Clin Oncol (2013)

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

Tekijä Rangwala, Reshma, Leone, Robert, Chang, Yunyoung C, Fecher, Leslie A, Schuchter, Lynn M, Kramer, Amy, Tan, Kay-See, Heitjan, Daniel F, Rodgers, Glenda, Gallagher, Maryann, Piao, Shengfu, Troxel, Andrea B, Evans, Tracey L, DeMichele, Angela M, Nathanson, Katherine L, O’Dwyer, Peter J, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, Amaravadi, Ravi K
Julkaistu 2014

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Tekijä Rangwala, Reshma, Chang, Yunyoung C, Hu, Janice, Algazy, Kenneth M, Evans, Tracey L, Fecher, Leslie A, Schuchter, Lynn M, Torigian, Drew A, Panosian, Jeffrey T, Troxel, Andrea B, Tan, Kay-See, Heitjan, Daniel F, DeMichele, Angela M, Vaughn, David J, Redlinger, Maryann, Alavi, Abass, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, O’Dwyer, Peter J, Amaravadi, Ravi K
Julkaistu 2014

Activity of the MEK Inhibitor Trametinib (GSK1120212) in Advanced Melanoma in a Phase I, Dose-escalation Trial

Tekijä Falchook, Gerald S, Lewis, Karl D, Infante, Jeffrey R, Gordon, Michael S, Vogelzang, Nicholas J, DeMarini, Douglas J, Sun, Peng, Moy, Christopher, Szabo, Stephen A., Roadcap, Lori T, Peddareddigari, Vijay G R, Lebowitz, Peter F, Le, Ngocdiep T, Burris, Howard A, Messersmith, Wells A, O'Dwyer, Peter J, Kim, Kevin B., Flaherty, Keith, Bendell, Johanna C., Gonzalez, Rene, Kurzrock, Razelle, Fecher, Leslie A
Julkaistu 2012

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Tekijä Rivera, Donna R., Peters, Solange, Panagiotou, Orestis A., Shah, Dimpy P., Kuderer, Nicole M., Hsu, Chih-Yuan, Rubinstein, Samuel M., Lee, Brendan J., Choueiri, Toni K., de Lima Lopes, Gilberto, Grivas, Petros, Painter, Corrie A., Rini, Brian I., Thompson, Michael A., Arcobello, Jonathan, Bakouny, Ziad, Doroshow, Deborah B., Egan, Pamela C., Farmakiotis, Dimitrios, Fecher, Leslie A., Friese, Christopher R., Galsky, Matthew D., Goel, Sanjay, Gupta, Shilpa, Halfdanarson, Thorvardur R., Halmos, Balazs, Hawley, Jessica E., Khaki, Ali Raza, Lemmon, Christopher A., Mishra, Sanjay, Olszewski, Adam J., Pennell, Nathan A., Puc, Matthew M., Revankar, Sanjay G., Schapira, Lidia, Schmidt, Andrew, Schwartz, Gary K., Shah, Sumit A., Wu, Julie T., Xie, Zhuoer, Yeh, Albert C., Zhu, Huili, Shyr, Yu, Lyman, Gary H., Warner, Jeremy L.
Julkaisussa Cancer Discov (2020)

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Tekijä Bettegowda, Chetan, Sausen, Mark, Leary, Rebecca J., Kinde, Isaac, Wang, Yuxuan, Agrawal, Nishant, Bartlett, Bjarne R., Wang, Hao, Luber, Brandon, Alani, Rhoda M., Antonarakis, Emmanuel S., Azad, Nilofer S., Bardelli, Alberto, Brem, Henry, Cameron, John L., Lee, Clarence C., Fecher, Leslie A., Gallia, Gary L., Gibbs, Peter, Le, Dung, Giuntoli, Robert L., Goggins, Michael, Hogarty, Michael D., Holdhoff, Matthias, Hong, Seung-Mo, Jiao, Yuchen, Juhl, Hartmut H., Kim, Jenny J., Siravegna, Giulia, Laheru, Daniel A., Lauricella, Calogero, Lim, Michael, Lipson, Evan J., Marie, Suely Kazue Nagahashi, Netto, George J., Oliner, Kelly S., Olivi, Alessandro, Olsson, Louise, Riggins, Gregory J., Sartore-Bianchi, Andrea, Schmidt, Kerstin, Shih, le-Ming, Oba-Shinjo, Sueli Mieko, Siena, Salvatore, Theodorescu, Dan, Tie, Jeanne, Harkins, Timothy T., Veronese, Silvio, Wang, Tian-Li, Weingart, Jon D., Wolfgang, Christopher L., Wood, Laura D., Xing, Dongmei, Hruban, Ralph H., Wu, Jian, Allen, Peter J., Schmidt, C. Max, Choti, Michael A., Velculescu, Victor E., Kinzler, Kenneth W., Vogelstein, Bert, Papadopoulos, Nickolas, Diaz, Luis A.
Julkaistu 2014